New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2013
10:00 EDTVITC, FMS, DVA, KWK, AGN, SD, DGI, BIG, UNFI, MCY, GRP, DDAIF, AWK, CWH, SCTYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Water (AWK) downgraded to Neutral from Buy at Citigroup... Big Lots (BIG) downgraded to Hold from Buy at Canaccord... DaVita (DVA) downgraded to Hold from Buy at Deutsche Bank... Daimler AG (DDAIF) downgraded to Neutral from Buy at Citigroup... DigitalGlobe (DGI) downgraded to Hold from Buy at Benchmark Co... Fresenius Medical (FMS) downgraded to Sector Perform from Outperform at RBC Capital... Granite Real Estate (GRP) downgraded to Sector Perform from Outperform at RBC Capital... Lincoln Educational (LINC) downgraded to Underperform from Market Perform at BMO Capital... SandRidge Energy (SD) downgraded to Underperform from Market Perform at BMO Capital... Vitacost.com (VITC) downgraded to Sell from Neutral at Roth Capital... Mercury General (MCY) downgraded to Neutral from Outperform at Macquarie... Allergan (AGN) downgraded to Neutral from Buy at Buckingham... SolarCity (SCTY) downgraded to Hold from Buy at Needham... United Natural Foods (UNFI) downgraded to Hold from Buy at Argus... Quicksilver Resources (KWK) downgraded to Hold from Buy at MLV Equity... CommonWealth REIT (CWH) downgraded to Sell from Hold at Stifel Nicolaus.
News For AWK;BIG;DVA;DDAIF;DGI;FMS;GRP;SD;VITC;MCY;AGN;SCTY;UNFI;KWK;CWH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 17, 2014
09:34 EDTAGNCombined Actavis-Allergan to be led by Actavis CEO Saunders
Actavis (ACT) and Allergan (AGN) said The combined company will be led by Brent Saunders, CEO and President of Actavis, and Paul Bisaro will remain Executive Chairman of the Board. The integration of the two companies will be led by the senior management teams of both companies, with integration planning to begin immediately in order to transition rapidly to a single company. Additionally, two members of the Allergan board of directors will be invited to join the Actavis Board of Directors following the completion of the transaction.
09:32 EDTAGNValeant says cannot justify paying $219 per share for Allergan
Valeant Pharmaceuticals (VRX) commented on the announcement that Allergan (AGN) and Actavis (ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of Allergan stock: "We have seen the announcement that Allergan and Actavis have made, and while we will review any such agreement in determining our course of action, Valeant cannot justify to its own shareholders paying a price of $219 or more per share for Allergan. Our business is performing extremely well as evidenced by our third quarter results, our expected strong fourth quarter, and our robust outlook for 2015, and I am confident in our continued ability to generate exceptional shareholder value. We will remain focused on delivering strong organic results and evaluating acquisition opportunities as we always have: prudently, in a disciplined manner, and in the best interests of our shareholders."
09:29 EDTAGNActavis to host conference call
Conference call to discuss the acquisition of Allergan will be held on November 17 at 10:30 am. Webcast Link
09:24 EDTAGNAllergan up over 5% to $209 after agreeing to be acquired by Actavis
Subscribe for More Information
09:21 EDTAGNActavis, Allergan transaction subject to approval of shareholders of both
Subscribe for More Information
09:20 EDTAGNActavis projects at least $1.8B in annual synergies from Allergan transaction
Subscribe for More Information
09:18 EDTAGNActavis sees free cash flow over $8B in 2016 following Allergan acquisition
Subscribe for More Information
09:16 EDTAGNActavis confirms deal to acquire Allergan for $219 in cash, stock
Subscribe for More Information
09:15 EDTAGNActavis confirms deal to acquire Allergan for $219 in cash and shares
Subscribe for More Information
09:10 EDTAGNActavis buying Allergan for $219 per share, CNBC reports
07:21 EDTFMSDanone mulls IPO for nutrition unit as sale talks disappoint, Reuters says
Subscribe for More Information
06:05 EDTAGNActavis close to buying Allergan for over $64B, Bloomberg reports
Subscribe for More Information
November 16, 2014
14:08 EDTDVADaVita announces collaboration with Medtronic
DaVita Kidney Care, a division of DaVita HealthCare Partners (DVA) and leading provider of kidney care services, announced a collaboration with Medtronic (MDT) to better understand cardiovascular health in end stage renal disease, ESRD patients. The collaboration will focus on developing a pilot program using Medtronic's Reveal LINQ Insertable Cardiac Monitoring system to identify cardiac arrhythmias in patients receiving dialysis. "Medtronic recently announced data at the American Society of Nephrology meeting that showed a higher incidence of arrhythmias in patients receiving hemodialysis," said Ven Manda, vice president, Renal Care Solutions at Medtronic. "We are pleased to pursue this collaboration with DaVita to monitor more patients and gather additional data that will further our understanding of the relationship between dialysis and cardiac events in ESRD patients." "Given the high incidence rate of cardiovascular disease and events in ESRD patients, we believe that by collaborating with Medtronic, we can gain knowledge to help improve the lives of ESRD patients," said Mahesh Krishnan, vice president for clinical innovation and public policy for DaVita HealthCare Partners. "Through the collaboration we expect to utilize innovative monitoring technology and data from our DaVita Kidney Care information systems across the country. This effort is poised to improve the lives of patients by proactively detecting and preventing cardiac complications."
14:02 EDTAGNAllergan, Actavis move closer to deal, WSJ reports
Subscribe for More Information
November 14, 2014
12:53 EDTSDOmega Advisors gives quarterly update on stakes
NEW STAKES: AerCap Holdings (AER), Nordic American Offshore (NAO), Melco Crown Entertainment (MPEL), Groupon (GRPN), and Ashland (ASH). INCREASED STAKES: QEP Resources (QEP), United Continental (UAL), Cabot Oil & Gas (COG), Actavis (ACT), and KAR Auction Services (KAR). DECREASED STAKES: Sprint (S), SandRidge Energy (SD), Sirius XM Holdings (SIRI), Kinder Morgan (KMI), and Transocean (RIG). LIQUIDATED STAKES: QUALCOMM (QCOM), Ocwen Financial (OCN), Freeport-McMoRan (FCX), Boston Scientific (BSX), and Capital One (COF).
November 13, 2014
09:40 EDTSCTYActive equity options trading
Subscribe for More Information
08:10 EDTSCTYSolarCity to install 20 MW on San Diego military housing
Secretary of the Navy Ray Mabus announced today that Navy and Marine Corps housing units in the San Diego area will receive rooftop solar photovoltaic, or PV, systems through a purchase power agreement between Lincoln Military Housing and SolarCity. The deal, one of SolarCity's largest residential undertakings under its SolarStrong Initiative, will provide solar power to nearly 6,000 homes across 27 privatized neighborhoods, with pending design and interconnection approvals could generate 20 MW or more of solar energy.
07:38 EDTSCTYBloomberg Link to hold a conference
The Year Ahead: 2015 is being held in Washington, D.C. with a pre-conference dinner on November 13 followed by company presentations on November 14,
07:23 EDTAGNValeant wooing doctors ahead of hoped for Allergan acquisition, WSJ says
Subscribe for More Information
06:43 EDTFMSFresenius Medical to acquire Cogent Healthcare, financial terms not disclosed
Fresenius Medical Care AG & Co. KGaA announced that Sound Physicians has entered into an agreement to acquire Cogent Healthcare with more than 650 providers, who offer hospitalist and intensivist services to more than 80 hospitals throughout the United States. Combined, the expanded Sound Physicians organization will now serve over 180 hospitals in 35 states with more than 2,250 providers including physicians and advanced care practitioners. Fresenius Medical Care is the majority shareholder in Sound. The company expects Cogent to generate approximately $250M in revenue in 2015 and expects the investment to be accretive to earnings within 18-24 months after closing including the transaction/integration cost and potential synergies. The investment will be financed through available cash. The parties involved agreed not to disclose the financial terms of the acquisition. The parties expect the transaction, which remains subject to regulatory clearance, to close this quarter.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use